Report in today's Australian Life Scientist
http://www.biotechnews.com.au/index.php?id=1494073475&eid=-2
============================================
Biotech briefs
Imugene to commercialise, Viralytics to present, Solbec eyes expansion
Dylan Bushell-Embling 09/09/2008 15:07:00
Animal health company Imugene [ASX: IMU] has reported small losses this financial year, but has made progress towards commercialising two products.
The company recorded a net loss of $1.9 million, and a net cash outflow of $1.2 million, and the company said it has developed two animal vaccines with healthy earning potential.
The first, a vaccine for porcine reproductive and respiratory syndrome (PPRS), has been tested and the company is currently seeking licensees. Imugene will soon undergo final trials of the second, a vaccine for coccidiosis in chickens, which will be tested to determine the optimal dosage.
- Forums
- ASX - By Stock
- prrs vaccine proves highly effective
Report in today's Australian Life...
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $431.8M |
Open | High | Low | Value | Volume |
5.9¢ | 5.9¢ | 5.6¢ | $1.037M | 17.94M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 1882949 | 5.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.9¢ | 399643 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 1874329 | 0.058 |
9 | 1728227 | 0.057 |
23 | 4466894 | 0.056 |
27 | 3648665 | 0.055 |
8 | 305000 | 0.054 |
Price($) | Vol. | No. |
---|---|---|
0.059 | 1360 | 1 |
0.060 | 2622845 | 17 |
0.061 | 773907 | 4 |
0.062 | 2227969 | 6 |
0.063 | 243179 | 3 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online